Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes
Abstract Multidrug-resistant tuberculosis (MDR-TB) is associated with a high rate of treatment failure. Since the 9 to 11-month shorter oral regimen in MDR-TB treatment includes pyrazinamide (PZA), it is essential to assess the susceptibility of MDR-TB strains to PZA to guide effective therapy. The...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Portfolio
2026-05-01
|
| Serie: | Scientific Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1038/s41598-026-53296-8 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|